University of Zurich
https://www.campus-schlieren.uzh.ch/en.html
8952 Schlieren, Wagistrasse 12
The University of Zurich (UZH) is Switzerland’s largest university, with seven faculties and a current enrollment of over 26,000 students. More than 5,000 highly qualified members of the teaching staff, including some 580 professors, teach and conduct research at the 150 University institutes. In the field of life sciences, the University of Zurich is well known for its groundbreaking research in medicine, immunology, neuroscience, and structural biology. In the interest of serving the community, the University of Zurich promotes the transfer of research-based knowledge to private enterprise, and our spin-off ventures and business partnerships regularly lead to the creation of attractive jobs in innovative fields.
University of Zurich
Wagistrasse 12
8952 Schlieren
46 Ergebnisse für "neoplastic" unter University of Zurich
Evidence of renal angiomyolipoma neoplastic stem cells arising from...
... of several different mesenchymal lineages, implying the existence of an unidentified AML neoplastic ... epithelial cells into neoplastic stem cells that serially propagate renal AML-like tumours in mice. mTOR ... Evidence of renal angiomyolipoma neoplastic stem cells arising from renal epithelial cells - Zurich ... Evidence of renal angiomyolipoma neoplastic stem cells arising from renal epithelial cells - Zurich ... Evidence of renal angiomyolipoma neoplastic stem cells arising from renal epithelial cells - Zurich ...
Computed tomographic-lymphography as a complementary technique for ...
... of neoplastic disease. As draining patterns of certain tumor types can be divergent from expected ... are routinely examined in order to define the spatial extent of neoplastic disease. As draining ... neoplastic disease. As draining patterns of certain tumor types can be divergent from expected anatomical ... are routinely examined in order to define the spatial extent of neoplastic disease. As draining ...
Somagenetix
https://www.wysszurich.ch/projects/somagenetix
8952 Schlieren, Wagistrasse 23
Gene therapy solutions for patients with severe inherited diseases.
Somagenetix
Wagistrasse 23
8952 Schlieren
98 Ergebnisse für "neoplastic" unter Somagenetix
The FDA approved PI3K inhibitor GDC-0941 enhances in vitro the anti...
... Maintenance Infos The FDA approved PI3K inhibitor GDC-0941 enhances in vitro the anti- neoplastic ... ; Dilloo, Dagmar (2018). The FDA approved PI3K inhibitor GDC-0941 enhances in vitro the anti- neoplastic ... The FDA approved PI3K inhibitor GDC-0941 enhances in vitro the anti- neoplastic efficacy of Axitinib ... The FDA approved PI3K inhibitor GDC-0941 enhances in vitro the anti- neoplastic efficacy of Axitinib ... The FDA approved PI3K inhibitor GDC-0941 enhances in vitro the anti- neoplastic efficacy of Axitinib ...
PD-1 and PD-L1 in neoplastic cells and the tumor microenvironment o...
... PD-1 and PD-L1 in neoplastic cells and the tumor microenvironment of Merkel cell carcinoma - Zurich ... PD-1 and PD-L1 in neoplastic cells and the tumor microenvironment of Merkel cell carcinoma - Zurich ... PD-1 and PD-L1 in neoplastic cells and the tumor microenvironment of Merkel cell carcinoma - Zurich ...
University Hospital Zurich, Research and Education Office
https://www.usz.ch/forschung/Seiten/default.aspx
8091 Zürich, Rämistrasse 100
The University Hospital Zurich is one of Switzerland’s largest hospitals and a pioneering institution in the field of clinical research. In its 40 departments and institutes, it assembles and practices all medical disciplines and enjoys an excellent reputation for state-of-the-art medicine, professional and com- passionate patient care, and groundbreaking bench-to-bedside translational medical research.
University Hospital Zurich, Research and Education Office
Rämistrasse 100
8091 Zürich
34 Ergebnisse für "neoplastic" unter University Hospital Zurich, Research and Education Office
Microsoft Word - MSCC ScoreSheed Print2.docx
... spinal instability in neoplastic disease: an evidence- based approach and expert consensus from the Spine ... Oncology Study Group. Spine (Phila Pa 1976) 2010;35:E1221-9. SINS - Spine Instability Neoplastic Score3 ... spinal instability in neoplastic disease: an evidence- based approach and expert consensus from the Spine ... Oncology Study Group. Spine (Phila Pa 1976) 2010;35:E1221-9. SINS - Spine Instability Neoplastic Score3 ...
Slide S IX 9a
... resection after chemotherapy). - Neoplastic cell population with signs of malignancy: cell and nuclear ... bone substance by neoplastic cells (sine qua non of diagnosis) Comment: Evidence of osteoid formation ... resection after chemotherapy). - Neoplastic cell population with signs of malignancy: cell and nuclear ... bone substance by neoplastic cells (sine qua non of diagnosis) Comment: Evidence of osteoid formation ...
Roche Glycart AG
https://www.roche.ch/en/sites/schlieren
8952 Schlieren, Wagistrasse 10
+41 43 215 10 00
The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.
Roche Glycart AG
Wagistrasse 10
8952 Schlieren
32 Ergebnisse für "neoplastic" unter Roche Glycart AG
uPath Ki-67 (30-9) image analysis, Breast
... neoplastic breast tissue. Related information Integrated and ready-to-use Validated for use with the ... images of formalin-fixed, paraffin-embedded (FFPE) neoplastic breast tissue captured on a VENTANA whole ... neoplastic breast tissue. Related information Digital pathology solutions Kontakta oss Prioritizing accuracy ...
uPath ER (SP1) image analysis, Breast
... of formalin-fixed, paraffin-embedded neoplastic breast tissue. Related information Advancing ... tumor region in images of formalin-fixed, paraffin-embedded neoplastic breast tissue. Related ...
Blutspende SRK Zürich
https://www.blutspendezuerich.ch/
8952 Schlieren, Rütistrasse 19
+41 58 272 52 52
info@zhbsd.ch
The Zurich Blood Transfusion Service SRK (ZHBSD) is a nonprofit foundation and independent partner in the healthcare sector. It ensures the supply of blood and blood products to patients in the Zurich region. Our products are made exclusively from voluntary, unpaid blood donations. We offer our services at cost-covering prices and without government subsidies. Along with ten other regional blood donation services in Switzerland, we are a member of the Swiss Red Cross Blood Donation Service (BSD SRK AG).
Blutspende SRK Zürich
Rütistrasse 19
8952 Schlieren
3 Ergebnisse für "neoplastic" unter Blutspende SRK Zürich
Engstroem_Poster Lausanne 2011v6
... vascular, cardial and pulmonal insufficiencies as well as neoplastic and proliferative conditions. In cases ... vascular, cardial and pulmonal insufficiencies as well as neoplastic and proliferative conditions. In cases ...
Expression of blood group genes by mesenchymal stem cells
... under sterile conditions from patients without metabolic or neoplastic diseases during orthopaedic ... glycoprotein, in normal and neoplastic human kidney. Journal of the American Society of Nephrology, 17, 2670 ... under sterile conditions from patients without metabolic or neoplastic diseases during orthopaedic ... glycoprotein, in normal and neoplastic human kidney. Journal of the American Society of Nephrology, 17, 2670 ...
ETH Entrepreneurship
https://ethz.ch/en/industry/entrepreneurship.html
8952 Schlieren, Wagistrasse 18
Excellence in entrepreneurship at ETH Zurich is driven by world-class research and education. It gives rise to groundbreaking new ventures that consolidate Switzerland’s technological leadership. Are you an aspiring entrepreneur seeking to find solutions to global challenges and create a better future for humanity. Or are you just interested in the entrepreneurial ecosystem at ETH Zurich? Browse our websites to find out more or reach out to the Entrepreneurship group, if you have any questions.
ETH Entrepreneurship
Wagistrasse 18
8952 Schlieren
3 Ergebnisse für "neoplastic" unter ETH Entrepreneurship
... personal copy NEOPLASTIC DISEASE Swiss FelineCancerRegistry: ARetrospective Study of the Occurrence of ... ., 2009; Brønden et al., 2010). For most neoplastic diseases in animals, there are no standard treatments ... personal copy NEOPLASTIC DISEASE Swiss FelineCancerRegistry: ARetrospective Study of the Occurrence of ... ., 2009; Brønden et al., 2010). For most neoplastic diseases in animals, there are no standard treatments ...
A Tissue-aware Gene Selection Approach for Analyzing Multi-tissue G...
... neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer,” P ... neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer,” P ...
Dualsystems Biotech AG
8952 Schlieren, Grabenstrasse 11a
+41 44 738 50 00
info@dualsystems.com
Dualsystems Biotech is a provider of proteomics services for industry and academia.
Dualsystems Biotech AG
Grabenstrasse 11a
8952 Schlieren
